{"AXP": {"Ticker": "AXP", "Company": "American Express", "Sector": "Financials", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$175"}, {"Date": "2022-06-06", "Rating": "Upgrade", "Organization": "Edward Jones", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-05-12", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": "$146"}, {"Date": "2022-04-11", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$200"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Edward Jones", "Robert W. Baird", "JP Morgan", "Wolfe Research"], "Price_Target": 129.25}, "ANTM": {"Ticker": "ANTM", "Company": "Anthem", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$550"}, {"Date": "2022-05-27", "Rating": "Resumed", "Organization": "Bernstein", "Rating_Change": "Outperform", "Target_Change": "$577 to $596"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Bernstein", "Loop Capital"], "Price_Target": 573.0}, "COF": {"Ticker": "COF", "Company": "Capital One Financial", "Sector": "Financials", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$145"}, {"Date": "2022-05-12", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Underperform", "Target_Change": "$86"}, {"Date": "2022-04-27", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$164 to $143"}, {"Date": "2022-03-24", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$185 to $189"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Piper Sandler", "Wolfe Research", "Robert W. Baird", "Citigroup"], "Price_Target": 140.75}, "CNC": {"Ticker": "CNC", "Company": "Centene Corporation", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$100"}, {"Date": "2022-05-27", "Rating": "Resumed", "Organization": "Bernstein", "Rating_Change": "Outperform", "Target_Change": "$111 to $108"}, {"Date": "2022-05-26", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$95 to $90"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Bernstein", "Loop Capital", "BofA Securities"], "Price_Target": 99.33}, "CF": {"Ticker": "CF", "Company": "CF Industries", "Sector": "Materials", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$123 to $99"}, {"Date": "2022-06-01", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$103"}, {"Date": "2022-04-14", "Rating": "Downgrade", "Organization": "Consumer Edge Research", "Rating_Change": "Overweight to Equal Weight", "Target_Change": ""}, {"Date": "2022-03-28", "Rating": "Downgrade", "Organization": "Scotiabank", "Rating_Change": "Sector Outperform to Sector Perform", "Target_Change": "$81 to $118"}], "Score": -1.25, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Citigroup", "Consumer Edge Research", "Scotiabank", "Barclays"], "Price_Target": 79.0}, "CI": {"Ticker": "CI", "Company": "Cigna", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Hold", "Target_Change": "$270"}, {"Date": "2022-05-27", "Rating": "Resumed", "Organization": "Bernstein", "Rating_Change": "Mkt Perform", "Target_Change": "$258 to $301"}, {"Date": "2022-05-26", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": "$265 to $300"}, {"Date": "2022-05-16", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$248 to $304"}, {"Date": "2022-05-09", "Rating": "Upgrade", "Organization": "Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$242 to $329"}], "Score": 1.2, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Loop Capital", "Bernstein", "JP Morgan", "BofA Securities", "Cowen"], "Price_Target": 300.8}, "CVS": {"Ticker": "CVS", "Company": "CVS Health", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$120"}, {"Date": "2022-05-27", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$122 to $112"}, {"Date": "2022-03-29", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$110"}], "Score": -0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Bernstein", "Loop Capital", "Deutsche Bank"], "Price_Target": 114.0}, "DOW": {"Ticker": "DOW", "Company": "Dow", "Sector": "Materials", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$82 to $60"}, {"Date": "2022-05-31", "Rating": "Downgrade", "Organization": "Alembic Global Advisors", "Rating_Change": "Overweight to Neutral", "Target_Change": "$75"}, {"Date": "2022-05-26", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$68"}, {"Date": "2022-05-23", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$84 to $78"}, {"Date": "2022-05-20", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$50 to $67"}, {"Date": "2022-04-22", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$70 to $82"}, {"Date": "2022-04-19", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Underperform to Peer Perform", "Target_Change": "$64"}, {"Date": "2022-04-19", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$64"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 8, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Piper Sandler", "Citigroup", "Wolfe Research", "Credit Suisse", "Alembic Global Advisors", "Evercore ISI"], "Price_Target": 69.75}, "FITB": {"Ticker": "FITB", "Company": "Fifth Third Bancorp", "Sector": "Financials", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$44"}, {"Date": "2022-04-28", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$52"}, {"Date": "2022-04-07", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": "$59 to $47"}, {"Date": "2022-03-28", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$56 to $50"}, {"Date": "2022-03-24", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "Wolfe Research", "Robert W. Baird", "Morgan Stanley", "Wells Fargo"], "Price_Target": 37.6}, "HCA": {"Ticker": "HCA", "Company": "HCA Healthcare", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$240"}, {"Date": "2022-05-27", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$273 to $271"}, {"Date": "2022-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$267"}], "Score": 1.33, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Bernstein", "Loop Capital", "Wells Fargo"], "Price_Target": 259.33}, "HUM": {"Ticker": "HUM", "Company": "Humana", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$510"}, {"Date": "2022-05-27", "Rating": "Initiated", "Organization": "Bernstein", "Rating_Change": "Mkt Perform", "Target_Change": "$480 to $506"}, {"Date": "2022-04-13", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$486 to $520"}], "Score": 1.33, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["UBS", "Bernstein", "Loop Capital"], "Price_Target": 512.0}, "MTB": {"Ticker": "MTB", "Company": "M&T Bank", "Sector": "Financials", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$200"}, {"Date": "2022-04-21", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Overweight", "Target_Change": "$179 to $238"}, {"Date": "2022-03-28", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Underweight", "Target_Change": "$185 to $179"}, {"Date": "2022-03-24", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": ""}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Citigroup", "Morgan Stanley", "Robert W. Baird"], "Price_Target": 153.25}, "UNH": {"Ticker": "UNH", "Company": "UnitedHealth Group", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$575"}, {"Date": "2022-05-27", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$561"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Bernstein", "Loop Capital"], "Price_Target": 568.0}, "UHS": {"Ticker": "UHS", "Company": "Universal Health Services", "Sector": "Health Care", "Updated": "2022-06-17", "Rating": [{"Date": "2022-06-17", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Hold", "Target_Change": "$115"}, {"Date": "2022-03-29", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": "$139"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Loop Capital", "Wells Fargo"], "Price_Target": 127.0}}